Related references
Note: Only part of the references are listed.Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity
Bin Bin Wu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Doxorubicin nanoformulations on therapy against cancer: An overview from the last 10 years
Natalia A. D'Angelo et al.
BIOMATERIALS ADVANCES (2022)
Acetylcholine receptor agonists provide cardioprotection in doxorubicin-induced cardiotoxicity via modulating muscarinic M2 and a7 nicotinic receptor expression
Nanthip Prathumsap et al.
TRANSLATIONAL RESEARCH (2022)
Mitochondrial dynamics regulate genome stability via control of caspase-dependent DNA damage
Kai Cao et al.
DEVELOPMENTAL CELL (2022)
Ethanol extracts of Rhaponticum uniflorum (L.) DC flowers attenuate doxorubicin-induced cardiotoxicity via alleviating apoptosis and regulating mitochondrial dynamics in H9c2 cells
Boqin Hu et al.
JOURNAL OF ETHNOPHARMACOLOGY (2022)
Total flavonoids of Selaginella tamariscina (P.Beauv.) Spring ameliorates doxorubicin-induced cardiotoxicity by modulating mitochondrial dysfunction and endoplasmic reticulum stress via activating MFN2/PERK
Liyuan Gao et al.
PHYTOMEDICINE (2022)
Mfn2-mediated mitochondrial fusion alleviates doxorubicin-induced cardiotoxicity with enhancing its anticancer activity through metabolic switch
Mingge Ding et al.
REDOX BIOLOGY (2022)
Cancer treatment and survivorship statistics, 2022
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
The Impairment of Cell Metabolism by Cardiovascular Toxicity of Doxorubicin Is Reversed by Bergamot Polyphenolic Fraction Treatment in Endothelial Cells
Cristina Algieri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Doxorubicin-induced cardiotoxicity: causative factors and possible interventions
Isobel C. Jones et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2022)
The Role of Mitochondrial Quality Control in Anthracycline-Induced Cardiotoxicity: From Bench to Bedside
Yukun Li et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)
Remote ischaemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity
Carlos Galan-Arriola et al.
CARDIOVASCULAR RESEARCH (2021)
Advances in Cardiotoxicity Induced by Altered Mitochondrial Dynamics and Mitophagy
Yiyuan Yin et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics
Apiwan Arinno et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Acetylcholinesterase inhibitor ameliorates doxorubicin-induced cardiotoxicity through reducing RIP1-mediated necroptosis
Thawatchai Khuanjing et al.
PHARMACOLOGICAL RESEARCH (2021)
Neuraminidase1 Inhibitor Protects Against Doxorubicin-Induced Cardiotoxicity via Suppressing Drp1-Dependent Mitophagy
Yating Qin et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Role of Inflammation and Redox Status on Doxorubicin-Induced Cardiotoxicity in Infant and Adult CD-1 Male Mice
Ana Reis-Mendes et al.
BIOMOLECULES (2021)
Klotho attenuated Doxorubicin-induced cardiomyopathy by alleviating Dynamin-related protein 1-mediated mitochondrial dysfunction
Xiaodong Zhuang et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2021)
Targeting Oxidative Stress, NLRP3 Inflammasome, and Autophagy by Fraxetin to Combat Doxorubicin-Induced Cardiotoxicity
Ahmed M. Kabel et al.
PHARMACEUTICALS (2021)
Luteolin Prevents Cardiac Dysfunction and Improves the Chemotherapeutic Efficacy of Doxorubicin in Breast Cancer
Youyang Shi et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Regulated cell death pathways in doxorubicin-induced cardiotoxicity
Effimia Christidi et al.
CELL DEATH & DISEASE (2021)
N-Alkylation of Anthracycline Antibiotics by Natural Sesquiterpene Lactones as a Way to Obtain Antitumor Agents with Reduced Side Effects
Margarita Neganova et al.
BIOMEDICINES (2021)
Early treatment with combination of SS31 and entresto effectively preserved the heart function in doxorubicin-induced dilated cardiomyopathic rat
Jui-Ning Yeh et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Cytoprotective Effect of Vitamin D on Doxorubicin-Induced Cardiac Toxicity in Triple Negative Breast Cancer
Kevin J. Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
An update of the molecular mechanisms underlying doxorubicin plus trastuzumab induced cardiotoxicity
Miguel Anjos et al.
LIFE SCIENCES (2021)
Cardiomyocyte mitochondrial dynamic-related lncRNA 1 (CMDL-1) may serve as a potential therapeutic target in doxorubicin cardiotoxicity
Lynn Htet Htet Aung et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Endurance Exercise Attenuates Doxorubicin-induced Cardiotoxicity
Youngil Lee et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2020)
Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy
Kendall B. Wallace et al.
CIRCULATION RESEARCH (2020)
Luteolin Attenuates Doxorubicin-Induced Cardiotoxicity Through Promoting Mitochondrial Autophagy
Haixia Xu et al.
FRONTIERS IN PHYSIOLOGY (2020)
NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy
Cheng Zeng et al.
REDOX BIOLOGY (2020)
Shenmai Injection Protects Against Doxorubicin-Induced Cardiotoxicity via Maintaining Mitochondrial Homeostasis
Lin Li et al.
FRONTIERS IN PHARMACOLOGY (2020)
Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission
Xinyue Liang et al.
PHARMACOLOGICAL RESEARCH (2020)
Inhibition of miR-23a attenuates doxorubicin-induced mitochondria-dependent cardiomyocyte apoptosis by targeting the PGC-1α/Drp1 pathway
Jingjing Du et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)
Doxorubicin-induced cardiomyocyte death is mediated by unchecked mitochondrial fission and mitophagy
Michael P. Catanzaro et al.
FASEB JOURNAL (2019)
Loss of Rubicon ameliorates doxorubicin-induced cardiotoxicity through enhancement of mitochondrial quality
Xiaoyun Liu et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
The phosphorylation status of Ser-637 in dynamin-related protein 1 (Drp1) does not determine Drp1 recruitment to mitochondria
Rong Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Mitochondrial dynamic modulation exerts cardiometabolic protection in obese insulin-resistant rats
Chayodom Maneechote et al.
CLINICAL SCIENCE (2019)
Mitochondrial quality control in cardiac cells: Mechanisms and role in cardiac cell injury and disease
Farzaneh G. Tahrir et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Melatonin improves cardiac and mitochondrial function during doxorubicin-induced cardiotoxicity: A possible role for peroxisome proliferator-activated receptor gamma coactivator 1-alpha and sirtuin activity?
Jenelle Govender et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Doxorubicin-induced mitophagy and mitochondrial damage is associated with dysregulation of the PINK1/parkin pathway
Jian Yin et al.
TOXICOLOGY IN VITRO (2018)
Exercise and Doxorubicin Treatment Modulate Cardiac Mitochondrial Quality Control Signaling
I. Marques-Aleixo et al.
CARDIOVASCULAR TOXICOLOGY (2018)
Foxo3a inhibits mitochondrial fission and protects against doxorubicin-induced cardiotoxicity by suppressing MIEF2
Luyu Zhou et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Doxorubicin-induced cardiomyocyte apoptosis: Role of mitofusin 2
Han Tang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2017)
Roles of mitochondrial dynamics modulators in cardiac ischaemia/reperfusion injury
Chayodom Maneechote et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
LCZ696 improves cardiac function via alleviating Drpl-mediated mitochondrial dysfunction in mice with doxorubicin-induced dilated cardiomyopathy
Yan Xia et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice
Vinodkumar B. Pillai et al.
ONCOTARGET (2017)
The Putative Drp1 Inhibitor mdivi-1 Is a Reversible Mitochondrial Complex I Inhibitor that Modulates Reactive Oxygen Species
Evan A. Bordt et al.
DEVELOPMENTAL CELL (2017)
Heme oxygenase-1 regulates mitochondrial quality control in the heart
Travis D. Hull et al.
JCI INSIGHT (2016)
Mitochondrial Dynamics - Mitochondrial Fission and Fusion in Human Diseases
Stephen L. Archer
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Attenuation of Doxorubicin-Induced Cardiotoxicity by mdivi-1: A Mitochondrial Division/Mitophagy Inhibitor
Mayel Gharanei et al.
PLOS ONE (2013)
A Small Molecule Promotes Mitochondrial Fusion in Mammalian Cells
Danling Wang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Doxorubicin-induccd cardiomyopathy from the cardiotoxic mechanisms to management
Genzou Takemura et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2007)